Abiopharma

Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa

Bausch Health Notification

RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO

UTHR: Notification

ResMed Inc. Daily Stock Update

“LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Included in China’s Commercial Insurance Innovative Drug List

Notification from Dominari Holdings Inc

UTHR: Notification

Bristol Myers Squibb - Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025

Exicure, Inc. - Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting